Andrew Obenshain - 10 Jan 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Helen C. Fu, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
10 Jan 2022
Net transactions value
-$73,623
Form type
4
Filing time
12 Jan 2022, 20:15:21 UTC
Previous filing
09 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Sale $7,876 -852 -0.33% $9.24 253,569 10 Jan 2022 Direct F1, F2
transaction BLUE Common Stock Sale $20,591 -2,190 -0.86% $9.40 251,379 10 Jan 2022 Direct F1, F3
transaction BLUE Common Stock Sale $45,156 -4,683 -1.9% $9.64 246,696 11 Jan 2022 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 The range in prices for the transaction reported on this line was $8.96 to $9.36. The average weighted price was $9.2445. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The range in prices for the transaction reported on this line was $9.385 to $9.42. The average weighted price was $9.4022. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The range in prices for the transaction reported on this line was $9.48 to $9.83. The average weighted price was $9.6426. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.